|
Real-time Estimate
Tradegate
09:31:58 07/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 59.08 EUR | -0.38% |
|
-2.39% | -6.85% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.52B | |||||
| 1,024B | |||||
| 663B | - | - | - | ||
| 453B | |||||
| 352B | |||||
| 304B |
Select your edition
All financial news and data tailored to specific country editions
